Arlington Partners’s CME Group CME Stock Holding History

Arlington Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-843	Closed	-$186K	–	17
2026 Q2	$186K	Buy	843 +49	+6%	+$13.6K	0.34%	58
2026 Q1	$235K	Buy	+794	New	+$236K	0.47%	54
2025 Q4	–	Sell	-18,787	Closed	-$5.08M	–	16
2025 Q3	$5.08M	Buy	18,787 +10,894	+138%	+$2.96M	1.75%	20
2025 Q2	$2.18M	Buy	+7,893	New	+$2.15M	0.8%	60
2023 Q3	–	Sell	-667	Closed	-$124K	–	415
2023 Q2	$124K	Sell	667 -208	-24%	-$38.4K	0.02%	214
2023 Q1	$168K	Buy	875 +713	+440%	+$129K	0.02%	142
2022 Q4	$27.2K	Buy	+162	New	+$28.2K	﹤0.01%	277
2020 Q3	–	Sell	-13	Closed	-$2K	–	144
2020 Q2	$2K	Hold	13	–	–	﹤0.01%	159
2020 Q1	$2K	Buy	+13	New	+$2.59K	﹤0.01%	244

Other funds holding CME

PineStone Asset Management Montreal, Quebec, Canada $15.4B AUM 14.92% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Arlington Partners's CME Position: Q3 2026 in Review

Arlington Partners sold out of CME Group (CME) in Q3 2026, closing a stake of 843 shares — an estimated $186K sold.

Arlington Partners first reported a position in CME in Q1 2020 and held it in 9 quarters. The position peaked at $5.08M in Q3 2025. 424 funds tracked by Wall St. Rank hold CME as of Q3 2026.

Arlington Partners reported no remaining CME Group position as of Q3 2026 after selling out during the quarter.
Arlington Partners sold 843 CME Group shares in Q3 2026, an estimated $186K.
Arlington Partners first reported a position in CME Group in Q1 2020 and held it in 9 quarters.
Arlington Partners's CME Group position peaked at $5.08M in Q3 2025.
424 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Arlington Partners's 13F filing for Q3 2026, filed 20 Oct 2026.